Prehospital Cerebral Oxygenation During Cardiopulmonary Resuscitation (CPR)

This study has been completed.
Sponsor:
Collaborator:
Ziekenhuis Oost-Limburg
Information provided by (Responsible Party):
Cornelia Genbrugge, Hasselt University
ClinicalTrials.gov Identifier:
NCT01806844
First received: March 6, 2013
Last updated: April 19, 2016
Last verified: April 2016
  Purpose
Near infrared spectroscopy (NIRS) is a technique that measures regional cerebral oxygenation in a non-invasive manner. Through the use of near infrared light, the difference between oxygenated and deoxygenated hemoglobin can be measured. By applying the Beer-Lamber law, a numeric result can be calculated. During a cardiac arrest, there is no stroke volume, no cardiac output and no cerebral perfusion. By using cerebral NIRS during out-of hospital cardiac arrest, low flow time and return of spontaneous circulation, this study wants to show the prognostic value of NIRS as extra monitoring.

Condition
Cardiac Arrest

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cerebral Oxygenation During Resuscitation and Post-resuscitation Phase

Resource links provided by NLM:


Further study details as provided by Hasselt University:

Primary Outcome Measures:
  • prognostic value [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Prognostic value of cerebral oxygenation during CPR


Enrollment: 200
Study Start Date: May 2013
Study Completion Date: November 2015
Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pre-hospital cardiac arrest
Criteria

Inclusion Criteria:

  • >16 year

Exclusion Criteria:

  • DNR code
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01806844

Locations
Belgium
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600
Universitair ziekenhuis Leuven
Leuven, Vlaams Brabant, Belgium, 3000
Ziekenhuis netwerk Antwerpen
Antwerpen, Belgium, 2000
GZA St Vincentius
Antwerp, Belgium
AZ Turnhout
Turnhout, Belgium
Sponsors and Collaborators
Hasselt University
Ziekenhuis Oost-Limburg
Investigators
Principal Investigator: Cornelia Genbrugge, MD Hasselt University
  More Information

Publications:
Responsible Party: Cornelia Genbrugge, Dr. Genbrugge, Hasselt University
ClinicalTrials.gov Identifier: NCT01806844     History of Changes
Other Study ID Numbers: Copernicus I 
Study First Received: March 6, 2013
Last Updated: April 19, 2016
Health Authority: Belgium: Ethics Committee

Keywords provided by Hasselt University:
Cardiac arrest
Cerebral oxygenation
Pre-hospital

Additional relevant MeSH terms:
Heart Arrest
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 22, 2016